Advertisement

Topics

Boehringer Ingelheim España, S.A. Company Profile

03:33 EDT 19th September 2018 | BioPortfolio

El grupo Boehringer Ingelheim es una de las 20 corporaciones farmacéuticas principales a nivel mundial. Con sede central en Ingelheim, Alemania, Boehringer Ingelheim cuenta con 144 filiales en 45 países y una plantilla de más de 36.000 empleados. Desde su creación en 1885, esta empresa de propiedad familiar ha estado comprometida con la investigación y desarrollo, la fabricación y la comercialización de productos nuevos de gran valor terapéutico para la medicina humana y veterinaria.En 2004, Boehringer Ingelheim declaró ventas netas por un valor de 8.200 millones de euros, al tiempo que invirtió en investigación y desarrollo aproximadamente una quinta parte de las ventas netas del área principal de negocio, las especialidades farmacéuticas de prescripción. Para más información sobre Boehringer Ingelheim, consulte en Internet la página web internacional www.boehringer-ingelheim.com.
El lema de la compañía es el de añadir valor a través de la innovación y éste se aplica en todos los ámbitos teniendo en cuenta, en todo momento, a clientes, empleados y a aquellas comunidades en las que opera.

Location

Prat de la Riba, s/n
Sant Cugat del Vallès
Barcelona
E-08173
Spain

Contact

Phone: 34 93 404 54 00
Fax: 34 93 404 54 84
Email: curriculum@bcn.boehringer-ingelheim.com


News Articles [330 Associated News Articles listed on BioPortfolio]

Boehringer Ingelheim i Uniwersytet Vanderbilt poszerzają współpracę w celu opracowania ...

-- Trzecia współpraca firmy Boehringer Ingelheim i Uniwersytetu Vanderbilt INGELHEIM, Niemcy i NASHVILLE, Tennessee, 13 marca 2018 r. /PRNewswire/ -- Koncern Boehringer Ingelheim i Read more...

PRESSESPIEGEL/Unternehmen: BOEHRINGER INGELHEIM, THYSSENKRUPP, COMMERZBANK, K+S, LUFTHANSA, 50HERTZ, DEUTSCHE GLASFASER, CISCO, HYPOVEREINSBANK

Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires. BOEHRINGER INGELHEIM - Der Pharmakonzern Boehringer Ingelheim strukturiert seine Wirkstoffproduktion um. ...

Spoločnosť Boehringer Ingelheim a Univerzita Vanderbilt rozširujú svoje partnerstvo s ...

-- Ide už o tretiu spoluprácu medzi spoločnosťou Boehringer Ingelheim a Univerzitou Vanderbilt INGELHEIM, Nemecko a NASHVILLE, Tennessee, 13. marca 2018 /PRNewswire/ -- Spoločnosť Boehring...

Boehringer Ingelheim Strikes a Series of Investments and Collaborations Worldwide

The last week has marked plenty of investment activity in operations, collaborations and PR the last week or two for Ingelheim, Germany-based Boehringer Ingelheim.

Boehringer Ingelheim acquires MabVax’s programme for solid tumours

Boehringer Ingelheim has entered an asset acquisition and licence agreement for US-based biotechnology firm MabVax Therapeutics’ programme designed to target...Read More... The post Boehringer Ingel...

Is Boehringer Ingelheim moving away from traditional medicines in favour of biopharmaceuticals?

Allan Hillgrove, Corporate Board Division, Pharma Marketing and Sales discusses the ongoing transformation of Boehringer Ingelheim’s portfolio.

Boehringer Ingelheim investiert in Forschungszentrum in Biberach

Das Pharmaunternehmen Boehringer Ingelheim baut für 230 Millionen Euro ein neues Entwicklungszentrum für biotechnisch produzierte Wirkstoffe. Dies sei ein weiterer wichtiger Baustein der langfrist.....

Boehringer Ingelheim And Vanderbilt Univ. To Develop Novel Cancer Treatment

NewsBoehringer Ingelheim and Vanderbilt University will extend their existing collaboration to develop novel anti-cancer compounds, focusing on new chemical therapeutics.

Drugs and Medications [68 Associated Drugs and Medications listed on BioPortfolio]

Zantac [Boehringer Ingelheim Pharmaceuticals, Inc.]

Zantac Drug Facts

Zantac [Boehringer Ingelheim Pharmaceuticals, Inc.]

Zantac Drug Facts

Zantac [Boehringer Ingelheim Pharmaceuticals, Inc.]

Zantac Drug Facts

Dulcolax balance [Boehringer Ingelheim Pharmaceuticals Inc]

Boehringer-Ingelheim Consumer Health Care Products Dulcolax Balance® Drug Facts

Pradaxa [Boehringer Ingelheim Pharmaceuticals Inc.]

These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for o...

PubMed Articles [11 Associated PubMed Articles listed on BioPortfolio]

Boehringer-Ingelheim Satellite Symposium Choosing the Right Controller Therapy in Pediatric Patients with Asthma.

Donated chemical probes for open science.

Potent, selective and broadly characterized small molecule modulators of protein function (chemical probes) are powerful research reagents. The pharmaceutical industry has generated many high-quality ...

Resúmenes al Español.

Resúmenes al Español.

Resúmenes al Español.

Clinical Trials [30 Associated Clinical Trials listed on BioPortfolio]

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

to evaluate the bioavailability of ambroxol hydrochloride soft pastilles (test formulation), manufactured by Bolder Arzneimittel GmbH & Co. KG to Boehringer Ingelheim compared to ambroxol ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions

The objective of this study was the bioequivalence of a Roxane Laboratories' Meloxicam tablets, 15 mg, to Mobic® Tablets, 15 mg (Boehringer Ingelheim) under fasting conditions using a sin...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Companies [52 Associated Companies listed on BioPortfolio]

Boehringer Ingelheim España, S.A.

El grupo Boehringer Ingelheim es una de las 20 corporaciones farmacéuticas principales a nivel mundial. Con sede central en Ingelheim, Alemania, Boehringer Ingelheim cuenta con 144 filiales en 45 pa...

Boehringer Ingelheim Limited

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146...

Boehringer Ingelheim Pharmaceuticals Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group ...

Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim erforscht, entwickelt, produziert und vermarktet Arzneimittel für Menschen in aller Welt.Mit 37.406 Mitarbeitern, die in 143 Gesellschaften auf allen Kontinenten beschäftigt sin...

Boehringer Ingelheim Pharmaceuticals, Inc.

Metabolism is one of Boehringer Ingelheim's core R&D areas and diabetes is one of the indications at the center of interest within the company's global research network. Boehringer Ingelheim is commit...

More Information about "Boehringer Ingelheim España, S.A." on BioPortfolio

We have published hundreds of Boehringer Ingelheim España, S.A. news stories on BioPortfolio along with dozens of Boehringer Ingelheim España, S.A. Clinical Trials and PubMed Articles about Boehringer Ingelheim España, S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Boehringer Ingelheim España, S.A. Companies in our database. You can also find out about relevant Boehringer Ingelheim España, S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record